| Report ID |
100498 |
| Drug Identification Number |
02248151 |
| Brand name |
ALPHAGAN P |
| Common or Proper name |
brimonidine tartrate |
| Company Name |
ALLERGAN INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
BRIMONIDINE TARTRATE |
| Strength(s) |
0.15% |
| Dosage form(s) |
SOLUTION |
| Route of administration |
OPHTHALMIC |
| Packaging size |
10ml |
| ATC code |
S01EA |
| ATC description |
ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage |
Demand increase for the drug. |
| Anticipated start date |
|
| Actual start date |
2019-12-06 |
| Estimated end date |
2020-01-07 |
| Actual end date |
2020-02-04 |
| Shortage status |
Resolved |
| Updated date |
2020-02-05 |
| Company comments |
Alternate size of Alphagan P 5ml is available. |
| Health Canada comments |
|
| Company contact information |
Company contact information;
Telephone number: 800-668-6424
Email address: MR-GENERAL_INQUIRY@allergan.com
Website address: allergan.ca
Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
